JOSHUA LAWRENCE DUNAIEF
Medical Practice in Philadelphia, PA

License number
Pennsylvania MD070121L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19104

Professional information

Joshua L Dunaief Photo 1

Dr. Joshua L Dunaief, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
Penn Eye Care Scheie Eye Institute
51 N 39Th St STE 1, Philadelphia 19104
(215) 662-8121 (Phone)
Certifications:
Ophthalmology, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Penn Eye Care Scheie Eye Institute
51 N 39Th St STE 1, Philadelphia 19104
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Penn Presbyterian Medical Center
51 North 39Th St, Philadelphia 19104
Education:
Medical School
Columbia University College Of Physicians and Surgeons
Graduated: 1996
Johns Hopkins University School Med
University Of MD Med Sys


Joshua Dunaief Photo 2

Joshua Dunaief, Philadelphia PA

Work:
Scheie Eye Institute
51 N 39Th St, Philadelphia, PA 19104 Childrens Health Care
3400 Spruce St, Philadelphia, PA 19104


Joshua Lawrence Dunaief Photo 3

Joshua Lawrence Dunaief, Philadelphia PA

Specialties:
Ophthalmologist
Address:
51 N 39Th St, Philadelphia, PA 19104
3400 Civic Center Blvd., Philadelphia, PA 19104
Education:
Doctor of Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology


Joshua Dunaief Photo 4

Use Of Deferiprone For Treatment And Prevention Of Iron-Related Eye Disorders

US Patent:
2013002, Jan 24, 2013
Filed:
Nov 12, 2009
Appl. No.:
13/138263
Inventors:
Michael Spino - Pickering, CA
Joshua Lawrence Dunaief - Philadelphia PA, US
Assignee:
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - Philadelphia PA
APOTEX TECHNOLOGIES INC. - Toronto ON
International Classification:
A61K 31/4422, A61P 25/02, A61P 27/02, A61P 9/10, A61P 27/06, A61P 27/12
US Classification:
514348
Abstract:
There is provided use of orally available or topically applied deferiprone for prevention of iron-induced eye damage. The use may be for preparation of a medicament or in a method of preventing iron-induced eye damage to an eye of a subject at risk for iron-induced eye damage, the method comprising administering a prophylactically effective amount of deferiprone to the subject. There is also provided the use of deferiprone for treatment of iron-related eye disorders. The use may be for preparation of a medicament or in a method of treatment of damage to an eye of a having eye damage associated with iron, the method comprising topically administering a therapeutically effective amount of deferiprone to the subject.